Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial.
Tomoko OkamotoTakami IshizukaReiko ShimizuYasuko AsahinaHarumasa NakamuraYuko ShimizuYoichiro NishidaTakanori YokotaYouwei LinWakiro SatoTakashi YamamuraPublished in: JMIR research protocols (2024)
DERR1-10.2196/46709.